Ad
related to: drugmaker
Search results
Drugmaker Sanofi partners OpenAI, Formation Bio on AI-powered drug development
Investing.com· 1 day agoDrugmaker Sanofi partners OpenAI, Formation Bio on AI-powered drug development
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
Reuters· 9 hours agoFrench drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters via Yahoo Finance· 1 day ago(Reuters) -GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of...
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Benzinga via Yahoo Finance· 15 hours agoTuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 17 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
People using popular drugs for weight loss, diabetes are more likely to be diagnosed with stomach...
CNN.com· 2 days agoInjected medications that treat diabetes and obesity increase the risk of a rare but serious side...
Eli Lilly’s stock on pace for record close as Crohn’s disease trial hits the mark
Market Watch· 14 hours agoEli Lilly & Co. LLY shares were on pace for a record closing high Tuesday after the drugmaker...
Analysis-Europe stock pickers go old-school to ride the next wave in AI
Reuters via Yahoo Finance· 39 minutes agoEuropean stock pickers are turning to more established sectors like utilities, professional data...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 1 day agoIn 2014, drugmaker Forest Laboratories and its parent, Actavis, had a $28 billion problem. Actavis...
AstraZeneca Aims for $80 Billion in Total Revenue by 2030
US News & World Report· 23 hours agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal ...